Recent advances in dyspnea.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 25560861)

Published in Chest on January 01, 2015

Authors

Donald A Mahler, Denis E O'Donnell

Articles by these authors

Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest (2007) 5.01

An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med (2012) 3.62

Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. Am J Respir Crit Care Med (2010) 2.56

Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest (2002) 2.02

Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med (2014) 2.00

Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 1.97

Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? Eur Respir J (2011) 1.83

Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance. Am J Respir Crit Care Med (2009) 1.79

Ventilatory and perceptual responses to cycle exercise in obese women. J Appl Physiol (1985) (2007) 1.67

An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63

Does the respiratory system limit exercise in mild chronic obstructive pulmonary disease? Am J Respir Crit Care Med (2013) 1.59

Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease. J Pain Symptom Manage (2011) 1.59

Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc (2007) 1.56

Effect of obesity on respiratory mechanics during rest and exercise in COPD. J Appl Physiol (1985) (2011) 1.53

American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest (2010) 1.46

Prioritizing research at the Canadian Thoracic Society and beyond. Can Respir J (2010) 1.39

Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest (2006) 1.30

Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J (2011) 1.20

Measuring the effects of COPD on the patient. Respir Med (2005) 1.13

Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease--practical issues: a Canadian Thoracic Society Clinical Practice Guideline. Can Respir J (2010) 1.10

The clinician/scientist in respirology--a vanishing phenotype! Can Respir J (2010) 1.09

Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity. COPD (2010) 1.09

Mechanisms of activity-related dyspnea in pulmonary diseases. Respir Physiol Neurobiol (2009) 1.08

Chemoreflex control of breathing during wakefulness in healthy men and women. J Appl Physiol (1985) (2004) 1.05

Sex differences in exertional dyspnea in patients with mild COPD: physiological mechanisms. Respir Physiol Neurobiol (2011) 1.04

Components of the COPD Assessment Test (CAT) associated with a diagnosis of COPD in a random population sample. COPD (2012) 1.04

Meaningful effect size and patterns of response of the transition dyspnea index. J Clin Epidemiol (2003) 1.02

Inflammation in COPD: implications for management. Am J Med (2012) 1.00

No room to breathe: the importance of lung hyperinflation in COPD. Prim Care Respir J (2013) 0.98

Dynamic hyperinflation during bronchoconstriction in asthma: implications for symptom perception. Chest (2006) 0.95

Comparison of continuous and discrete measurements of dyspnea during exercise in patients with COPD and normal subjects. Chest (2004) 0.94

Proposing a standardized method for evaluating patient report of the intensity of dyspnea during exercise testing in COPD. Int J Chron Obstruct Pulmon Dis (2012) 0.94

Chronic obstructive pulmonary disease in men and women: myths and reality. Proc Am Thorac Soc (2009) 0.93

Recent advances in COPD disease management with fixed-dose long-acting combination therapies. Expert Rev Respir Med (2014) 0.92

Evolution of dyspnea during exercise in chronic obstructive pulmonary disease: impact of critical volume constraints. Am J Respir Crit Care Med (2011) 0.91

Effects of obesity on perceptual and mechanical responses to bronchoconstriction in asthma. Am J Respir Crit Care Med (2009) 0.91

The Physicians' Practice Assessment Questionnaire on asthma and COPD. Respir Med (2010) 0.91

Effect of obesity on constant workrate exercise in hyperinflated men with COPD. BMC Pulm Med (2010) 0.90

Impact of pulmonary rehabilitation on the major dimensions of dyspnea in COPD. COPD (2013) 0.90

Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. Can Respir J (2012) 0.89

Bronchodilator responsiveness and reported respiratory symptoms in an adult population. PLoS One (2013) 0.89

Sex differences in the perceived intensity of breathlessness during exercise with advancing age. J Appl Physiol (1985) (2008) 0.87

Effect of biventricular pacing on ventilatory and perceptual responses to exercise in patients with stable chronic heart failure. J Appl Physiol (1985) (2009) 0.87

Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD. Respir Med (2011) 0.86

Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD. Ann Am Thorac Soc (2015) 0.85

Physiologic characterization of the chronic bronchitis phenotype in GOLD grade IB COPD. Chest (2015) 0.85

Ventilatory constraints and dyspnea during exercise in chronic obstructive pulmonary disease. Appl Physiol Nutr Metab (2007) 0.85

Respiratory function and the obesity paradox. Curr Opin Clin Nutr Metab Care (2010) 0.85

Mechanical ventilatory constraints during incremental cycle exercise in human pregnancy: implications for respiratory sensation. J Physiol (2008) 0.85

Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease. Ann Am Thorac Soc (2014) 0.84

Inspiratory Capacity during Exercise: Measurement, Analysis, and Interpretation. Pulm Med (2013) 0.83

Exertional dyspnea in chronic obstructive pulmonary disease: mechanisms and treatment approaches. Curr Opin Pulm Med (2010) 0.82

Effects of human pregnancy on the ventilatory chemoreflex response to carbon dioxide. Am J Physiol Regul Integr Comp Physiol (2005) 0.82

Muscle blood-flow dynamics at exercise onset: do the limbs differ? Med Sci Sports Exerc (2006) 0.82

[Canadian Thoracic Society COPD guidelines: summary of highlights for family doctors]. Can Respir J (2004) 0.81

Effect of fluticasone/salmeterol combination on dyspnea and respiratory mechanics in mild-to-moderate COPD. Respir Med (2013) 0.81

Neuromodulatory effect of endogenous opioids on the intensity and unpleasantness of breathlessness during resistive load breathing in COPD. COPD (2011) 0.81

Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD. Eur Respir J (2013) 0.81

Effects of pregnancy, obesity and aging on the intensity of perceived breathlessness during exercise in healthy humans. Respir Physiol Neurobiol (2009) 0.81

Physiological mechanisms of hyperventilation during human pregnancy. Respir Physiol Neurobiol (2008) 0.81

Effects of dead space loading on neuro-muscular and neuro-ventilatory coupling of the respiratory system during exercise in healthy adults: implications for dyspnea and exercise tolerance. Respir Physiol Neurobiol (2011) 0.81

Should mild COPD be treated? Evidence for early pharmacological intervention. Drugs (2013) 0.81

The role of pharmacotherapy in mild to moderate chronic obstructive pulmonary disease. Ther Adv Respir Dis (2011) 0.80

Bronchodilator effect on ventilatory, pulmonary gas exchange, and heart rate kinetics during high-intensity exercise in COPD. Eur J Appl Physiol (2009) 0.80

Performance during constant workrate cycling exercise in women with COPD and hyperinflation. COPD (2009) 0.79

Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment. Expert Rev Respir Med (2014) 0.79

The role of tiotropium bromide, a long-acting anticholinergic bronchodilator, in the management of COPD. Treat Respir Med (2005) 0.79

Recent advances in pharmacotherapy for dyspnea in COPD. Curr Opin Pharmacol (2011) 0.78

Advantages of endurance treadmill walking compared with cycling to assess bronchodilator therapy. Chest (2009) 0.78

Effects of human pregnancy and advancing gestation on respiratory discomfort during exercise. Respir Physiol Neurobiol (2006) 0.78

Is sustained pharmacologic lung volume reduction now possible in COPD? Chest (2006) 0.78

Idiopathic pulmonary fibrosis: new insights on functional characteristics at diagnosis. Can Respir J (2014) 0.78

Ventilation Distribution Heterogeneity at Rest as a Marker of Exercise Impairment in Mild-to-Advanced COPD. COPD (2014) 0.77

[Canadian Thoracic Society COPD guidelines: summary of highlights for family doctors]. Can Respir J (2003) 0.77

Prospective Use of Descriptors of Dyspnea to Diagnose Common Respiratory Diseases. Chest (2015) 0.77

New physiological insights into dyspnea and exercise intolerance in chronic obstructive pulmonary disease patients. Expert Rev Respir Med (2012) 0.77

Perceptual and physiologic responses during treadmill and cycle exercise in patients with COPD. Chest (2008) 0.77

One-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD. Chest (2014) 0.76

Chemical and mechanical adaptations of the respiratory system at rest and during exercise in human pregnancy. Appl Physiol Nutr Metab (2007) 0.76

Is physical activity anti-inflammatory on the airways? Thorax (2007) 0.75

Is the men's marathon world record 25 years behind the women's record? J Appl Physiol (1985) (2011) 0.75

More is better once again! J Cardiopulm Rehabil (2005) 0.75

Can an 86-year-old woman with advanced lung disease be a world class athlete? Respir Physiol Neurobiol (2012) 0.75

Pulmonary edema in athletes: methodology or meaningful physiology? J Appl Physiol (1985) (2010) 0.75

Hit the dyspnea target! J Cardiopulm Rehabil (2003) 0.75

The clinical physiology and integrative neurobiology of dyspnea: introduction to the Special Issue of Respir. Physiol. Neurobiol. Respir Physiol Neurobiol (2009) 0.75

Response. Chest (2014) 0.75

Are you fluent in the language of dyspnea? Chest (2008) 0.75

Cellular assessment of muscle in COPD: case studies of two males. Int J Gen Med (2009) 0.75

McArdle's disease presenting as unexplained dyspnea in a young woman. Can Respir J (2004) 0.75

The Lung Association Leadership Conference--an opportunity for change. Can Respir J (2010) 0.75

Heart, lungs, and muscle interplay in worsening activity-related breathlessness in advanced cardiopulmonary disease. Curr Opin Support Palliat Care (2020) 0.75

The increased ventilatory response to exercise in pregnancy reflects alterations in the respiratory control systems ventilatory recruitment threshold for CO2. Respir Physiol Neurobiol (2010) 0.75

Respiratory sensation and ventilatory mechanics during induced bronchoconstriction in spontaneously breathing low cervical quadriplegia. Am J Respir Crit Care Med (2002) 0.75

Cardiopulmonary exercise testing. Pulm Med (2013) 0.75

The impact of human pregnancy on perceptual responses to chemoreflex vs. exercise stimulation of ventilation: a retrospective analysis. Respir Physiol Neurobiol (2010) 0.75

Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD. Respir Med (2011) 0.75

Mechanisms of activity-related breathlessness in healthy human pregnancy. Eur J Appl Physiol (2009) 0.75

It's about time--directing our attention toward modifying the course of COPD. Respir Med (2008) 0.75